311 related articles for article (PubMed ID: 34791548)
1. Apical approach in periodontal reconstructive surgery with enamel matrix derivate and enamel matrix derivate plus bone substitutes: a randomized, controlled clinical trial.
Moreno Rodríguez JA; Ortiz Ruiz AJ
Clin Oral Investig; 2022 Mar; 26(3):2793-2805. PubMed ID: 34791548
[TBL] [Abstract][Full Text] [Related]
2. Addition of enamel matrix derivatives to bone substitutes for the treatment of intrabony defects: A systematic review, meta-analysis and trial sequential analysis.
Troiano G; Laino L; Zhurakivska K; Cicciù M; Lo Muzio L; Lo Russo L
J Clin Periodontol; 2017 Jul; 44(7):729-738. PubMed ID: 28477366
[TBL] [Abstract][Full Text] [Related]
3. Clinical outcomes of the entire papilla preservation technique with and without biomaterials in the treatment of isolated intrabony defects: A randomized controlled clinical trial.
Aslan S; Buduneli N; Cortellini P
J Clin Periodontol; 2020 Apr; 47(4):470-478. PubMed ID: 31925811
[TBL] [Abstract][Full Text] [Related]
4. Treatment of intrabony defects with enamel matrix proteins and guided tissue regeneration. A prospective controlled clinical study.
Sculean A; Windisch P; Chiantella GC; Donos N; Brecx M; Reich E
J Clin Periodontol; 2001 May; 28(5):397-403. PubMed ID: 11350501
[TBL] [Abstract][Full Text] [Related]
5. Supra-alveolar attachment gain in the treatment of combined intra-suprabony periodontal defects by non-incised papillae surgical approach.
Moreno Rodríguez JA; Ortiz Ruiz AJ; Caffesse RG
J Clin Periodontol; 2019 Sep; 46(9):927-936. PubMed ID: 31190409
[TBL] [Abstract][Full Text] [Related]
6. Four-year results following treatment of intrabony periodontal defects with an enamel matrix derivative alone or combined with a biphasic calcium phosphate.
Pietruska M; Pietruski J; Nagy K; Brecx M; Arweiler NB; Sculean A
Clin Oral Investig; 2012 Aug; 16(4):1191-7. PubMed ID: 21881869
[TBL] [Abstract][Full Text] [Related]
7. Clinical outcomes following regenerative therapy of non-contained intrabony defects using a deproteinized bovine bone mineral combined with either enamel matrix derivative or collagen membrane.
Iorio-Siciliano V; Andreuccetti G; Blasi A; Matarasso M; Sculean A; Salvi GE
J Periodontol; 2014 Oct; 85(10):1342-50. PubMed ID: 24835417
[TBL] [Abstract][Full Text] [Related]
8. Ten-year results following treatment of intrabony defects with an enamel matrix protein derivative combined with either a natural bone mineral or a β-tricalcium phosphate.
Döri F; Arweiler NB; Szántó E; Agics A; Gera I; Sculean A
J Periodontol; 2013 Jun; 84(6):749-57. PubMed ID: 22873657
[TBL] [Abstract][Full Text] [Related]
9. The role of surgical flap design (minimally invasive flap vs. extended flap with papilla preservation) on the healing of intrabony defects treated with an enamel matrix derivative: a 12-month two-center randomized controlled clinical trial.
Windisch P; Iorio-Siciliano V; Palkovics D; Ramaglia L; Blasi A; Sculean A
Clin Oral Investig; 2022 Feb; 26(2):1811-1821. PubMed ID: 34491446
[TBL] [Abstract][Full Text] [Related]
10. Treatment of intrabony defects using guided tissue regeneration or enamel matrix derivative: a 3-year prospective randomized clinical study.
Crea A; Dassatti L; Hoffmann O; Zafiropoulos GG; Deli G
J Periodontol; 2008 Dec; 79(12):2281-9. PubMed ID: 19053918
[TBL] [Abstract][Full Text] [Related]
11. The effect of postsurgical antibiotics on the healing of intrabony defects following treatment with enamel matrix proteins.
Sculean A; Blaes A; Arweiler N; Reich E; Donos N; Brecx M
J Periodontol; 2001 Feb; 72(2):190-5. PubMed ID: 11288792
[TBL] [Abstract][Full Text] [Related]
12. Enamel matrix derivative (Emdogain) for periodontal tissue regeneration in intrabony defects. A Cochrane systematic review.
Esposito M; Grusovin MG; Papanikolaou N; Coulthard P; Worthington HV
Eur J Oral Implantol; 2009; 2(4):247-66. PubMed ID: 20467602
[TBL] [Abstract][Full Text] [Related]
13. Periodontal reconstructive surgery of deep intraosseous defects using an apical approach. Non-incised papillae surgical approach (NIPSA): A retrospective cohort study.
Moreno Rodríguez JA; Ortiz Ruiz AJ; Caffesse RG
J Periodontol; 2019 May; 90(5):454-464. PubMed ID: 30421495
[TBL] [Abstract][Full Text] [Related]
14. Treatment of intrabony periodontal defects in controlled diabetic patients with an enamel matrix derivative: a split-mouth randomized clinical trial.
Cimões R; Santiago LM; de França Caldas Júnior A; de Carvalho Farias Vajgel B; Perussolo J; Donos N
Clin Oral Investig; 2022 Mar; 26(3):2479-2489. PubMed ID: 34643808
[TBL] [Abstract][Full Text] [Related]
15. Supracrestal soft tissue preservation with enamel matrix proteins in treatment of deep intrabony defects.
Trombelli L; Bottega S; Zucchelli G
J Clin Periodontol; 2002 May; 29(5):433-9. PubMed ID: 12060426
[TBL] [Abstract][Full Text] [Related]
16. Enamel matrix proteins in the regenerative therapy of deep intrabony defects.
Tonetti MS; Lang NP; Cortellini P; Suvan JE; Adriaens P; Dubravec D; Fonzar A; Fourmousis I; Mayfield L; Rossi R; Silvestri M; Tiedemann C; Topoll H; Vangsted T; Wallkamm B
J Clin Periodontol; 2002 Apr; 29(4):317-25. PubMed ID: 11966929
[TBL] [Abstract][Full Text] [Related]
17. Clinical outcomes after treatment of non-contained intrabony defects with enamel matrix derivative or guided tissue regeneration: a 12-month randomized controlled clinical trial.
Siciliano VI; Andreuccetti G; Siciliano AI; Blasi A; Sculean A; Salvi GE
J Periodontol; 2011 Jan; 82(1):62-71. PubMed ID: 20809859
[TBL] [Abstract][Full Text] [Related]
18. Clinical comparison of an enamel matrix derivative used alone or in combination with a bovine-derived xenograft for the treatment of periodontal osseous defects in humans.
Velasquez-Plata D; Scheyer ET; Mellonig JT
J Periodontol; 2002 Apr; 73(4):433-40. PubMed ID: 11990445
[TBL] [Abstract][Full Text] [Related]
19. Microsurgical access flap and enamel matrix derivative for the treatment of periodontal intrabony defects: a controlled clinical study.
Wachtel H; Schenk G; Böhm S; Weng D; Zuhr O; Hürzeler MB
J Clin Periodontol; 2003 Jun; 30(6):496-504. PubMed ID: 12795787
[TBL] [Abstract][Full Text] [Related]
20. Clinical evaluation of demineralized freeze-dried bone allograft and enamel matrix derivative versus enamel matrix derivative alone for the treatment of periodontal osseous defects in humans.
Gurinsky BS; Mills MP; Mellonig JT
J Periodontol; 2004 Oct; 75(10):1309-18. PubMed ID: 15562907
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
